FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Multiple Dietary Supplement Violations at ForYou

[ Price : $8.95]

FDA warns dietary supplement manufacturer ForYou, Inc., about CGMP and other violations in its production and distribution of diet...

MDIC Forms 5G Healthcare Technology Working Group

[ Price : $8.95]

The Medical Device Innovation Consortium says it has launched a stakeholder working group to address 5G-enabled healthcare technol...

FDA Approves PET Imaging Prostate Cancer Drug

[ Price : $8.95]

FDA approves Gallium 68 PSMA-11 for use in PET imaging of prostate-specific membrane antigen in men with prostate cancer.

Company Selling Unapproved Home Covid Tests: FDA

[ Price : $8.95]

FDA warns Industry Lab Diagnostic Partners that it is distributing an unapproved home Covid-19 test kit.

Baxter Recalls Spectrum Infusion Pumps

[ Price : $8.95]

Baxter Healthcare recalls its Sigma Spectrum Infusion Pumps with Master Drug Library and the Baxter Spectrum IQ Infusion Systems w...

Genentech Gets New Indication for Xolair

[ Price : $8.95]

FDA approves a Genentech supplemental BLA for Xolair (omalizumab) for the add-on maintenance treatment of nasal polyps in adult pa...

Guide on Gastric pH-Dependent Drug Interactions

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Evaluation of Gastric pH-Dependent Drug Interactions With A...

Hahn Summoned to White House About Vaccine Delay

[ Price : $8.95]

President Trumps chief of staff Mark Meadows summons FDA commissioner Stephen Hahn to the White House 12/1 to learn why the agency...

FDA Recognizes A2LA for ASCA Pilot

[ Price : $8.95]

FDA recognizes A2LA to assess testing laboratories for the Accreditation Scheme for Conformity Assessment pilot program.

After FDA Meeting, Minerva Continuing Roluperidone Development

[ Price : $8.95]

Minerva Neurosciences says it believes it can address negative FDA comments about two roluperidone studies through published regul...